31st Annual Congress of the World Muscle Society Rationale and design of a safety, tolerability, andlong-term efficacy study of forazapadin (SAT-3247)in facioscapulohumeral[...]

Satellos Bioscience Inc. published this content on September 18, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 03, 2026 at 04:18 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]